329 related articles for article (PubMed ID: 2454362)
1. Acute hemodynamic effects of the vasodilating and beta-blocking agent carvedilol in comparison to propranolol.
Wendt T; van der Does R; Schräder R; Landgraf H; Kober G
J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S147-50. PubMed ID: 2454362
[TBL] [Abstract][Full Text] [Related]
2. Acute hemodynamic effects of carvedilol in comparison with propranolol in patients with coronary heart disease.
Wendt T
Clin Investig; 1992; 70 Suppl 1():S93-7. PubMed ID: 1350491
[TBL] [Abstract][Full Text] [Related]
3. Acute and long-term hemodynamic effects of carvedilol, a combined beta-adrenoceptor blocking and precapillary vasodilating agent, in hypertensive patients.
Eggertsen R; Sivertsson R; Andrén L; Hansson L
J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S97-100. PubMed ID: 2454378
[TBL] [Abstract][Full Text] [Related]
4. Carvedilol in hypertension: effects on hemodynamics and 24-hour blood pressure.
Lund-Johansen P; Omvik P; Nordrehaug JE; White W
J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S27-34. PubMed ID: 1378146
[TBL] [Abstract][Full Text] [Related]
5. Influence of carvedilol and propranolol on coronary blood flow.
Sievert H; Frey G; Schräder R; Schmidt T; van der Does R; Kaltenbach M; Kober G
Eur J Clin Pharmacol; 1990; 38 Suppl 2():S122-4. PubMed ID: 1974502
[TBL] [Abstract][Full Text] [Related]
6. Haemodynamics of carvedilol in normal subjects compared with propranolol, pindolol, and labetalol.
Tomlinson B; Cronin CJ; Graham BR; Prichard BN
J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S69-75. PubMed ID: 2454372
[TBL] [Abstract][Full Text] [Related]
7. Resting and postexercise hemodynamic effects of carvedilol, a beta-adrenergic blocker and precapillary vasodilator in hypertensive patients.
Leonetti G; Sampieri L; Cuspidi C; Boselli L; Terzoli L; Rupoli L; Zanchetti A
J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S94-6. PubMed ID: 2454377
[TBL] [Abstract][Full Text] [Related]
8. Effect of carvedilol on ambulatory blood pressure, renal hemodynamics, and cardiac function in essential hypertension.
Dupont AG; Van der Niepen P; Taeymans Y; Ingels M; Piepsz A; Bossuyt AM; Block P; Six RO; Jonckheer MH; Vanhaelst L
J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S130-6. PubMed ID: 2454359
[TBL] [Abstract][Full Text] [Related]
9. Carvedilol, a new nonselective beta-blocker with intrinsic anti- Alpha1-adrenergic activity, has a greater portal hypotensive effect than propranolol in patients with cirrhosis.
Bañares R; Moitinho E; Piqueras B; Casado M; García-Pagán JC; de Diego A; Bosch J
Hepatology; 1999 Jul; 30(1):79-83. PubMed ID: 10385642
[TBL] [Abstract][Full Text] [Related]
10. Effect of carvedilol and metoprolol on blood pressure, blood flow, and vascular resistance.
Morgan T; Snowden R; Butcher L
J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S124-9. PubMed ID: 2454358
[TBL] [Abstract][Full Text] [Related]
11. Beta-adrenoceptor blockade and vasodilatation in essential hypertension. Hemodynamic studies at rest and during exposure to stress.
Eggertsen R
Acta Med Scand Suppl; 1984; 689():1-46. PubMed ID: 6151343
[TBL] [Abstract][Full Text] [Related]
12. Effects of adrenoceptor blocking drugs on cardiovascular responsiveness to passive orthostasis: a placebo-controlled double-blind study.
Nieminen T; Ylitalo R; Kööbi T; Ylitalo P; Kähönen M
Arzneimittelforschung; 2005; 55(4):205-11. PubMed ID: 15901043
[TBL] [Abstract][Full Text] [Related]
13. Vasodilating mechanism and response to physiological pressor stimuli of acute doses of carvedilol compared with labetalol, propranolol and hydralazine.
Tomlinson B; Bompart F; Graham BR; Liu JB; Prichard BN
Drugs; 1988; 36 Suppl 6():37-47. PubMed ID: 2908303
[TBL] [Abstract][Full Text] [Related]
14. Vasodilatory effects of carvedilol and pindolol.
Sundberg S; Tiihonen K; Gordin A
J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S76-80. PubMed ID: 2454373
[TBL] [Abstract][Full Text] [Related]
15. Effects of carvedilol and propranolol on circulatory regulation and oxygenation in cirrhosis: a randomised study.
Hobolth L; Bendtsen F; Hansen EF; Møller S
Dig Liver Dis; 2014 Mar; 46(3):251-6. PubMed ID: 24290869
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of carvedilol in exercise-induced myocardial ischemia.
Kaski JC; Rodriguez-Plaza L; Brown J; Maseri A
J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S137-40. PubMed ID: 2454360
[TBL] [Abstract][Full Text] [Related]
17. [Neither propranolol nor the vasodilating beta-blocker carvedilol have a direct effect on coronary resistance vessels].
Sievert H; Schmidt T; Frey G; Schräder R; van der Does R; Kaltenbach M; Kober G
Z Kardiol; 1991 Jan; 80(1):15-9. PubMed ID: 1674632
[TBL] [Abstract][Full Text] [Related]
18. A new molecule with vasodilating and beta-adrenoceptor blocking properties.
Abshagen U
J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S23-32. PubMed ID: 2454364
[TBL] [Abstract][Full Text] [Related]
19. Comparative effectiveness of carvedilol and propranolol on glycemic control and insulin resistance associated with L-thyroxin-induced hyperthyroidism--an experimental study.
Bhatt P; Makwana D; Santani D; Goyal R
Can J Physiol Pharmacol; 2007 May; 85(5):514-20. PubMed ID: 17632586
[TBL] [Abstract][Full Text] [Related]
20. The effects of 2 beta-receptor blocking agents on the microcirculation of healthy subjects and of hypertensive patients.
Albrecht M; Haustein KO
Int J Clin Pharmacol Ther; 1997 Dec; 35(12):580-6. PubMed ID: 9455718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
